Guardant Health
GH
#1510
Rank
โ‚ฌ12.27 B
Marketcap
94,50ย โ‚ฌ
Share price
1.32%
Change (1 day)
163.72%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚ฌ12.27 Billion

As of January 2026 Guardant Health has a market cap of โ‚ฌ12.27 Billion. This makes Guardant Health the world's 1510th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ12.27 B7.8%
2025โ‚ฌ11.38 B215.01%
2024โ‚ฌ3.61 B21.69%
2023โ‚ฌ2.97 B14.34%
2022โ‚ฌ2.59 B-71.07%
2021โ‚ฌ8.97 B-14.29%
2020โ‚ฌ10.47 B59.92%
2019โ‚ฌ6.55 B132.46%
2018โ‚ฌ2.81 B

End of Day market cap according to different sources

On Jan 10th, 2026 the market cap of Guardant Health was reported to be:

โ‚ฌ11.91 Billion
by Nasdaq info icon info icon
โ‚ฌ12.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Natera
NTRA
โ‚ฌ28.02 B 128.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚ฌ1.79 B-85.37%๐Ÿ‡บ๐Ÿ‡ธ USA